ACTRN12612000238875已完成未知
Multi-centre, single arm study to evaluate performance and safety of the CINCOR contrast media removal system in chronic renal disease patients requiring a percutaneous coronary intervention procedure.
Osprey Medical Pty Ltd0 个研究点目标入组 42 人开始时间: 2012年2月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Chronic renal disease and requires a percutaneous coronary intervention procedure.
排除标准
- •Not eligable for percutaneous coronary procedure or has an allergy to contrast media, unable/unwilling to provide consent, is pregnant.
研究者
相似试验
进行中（未招募）
1 期
OncoSur Analysis of the Treatment in Third Line of ABC with Eribuli-MedDRA version: 14.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2013-001416-30-ESFundación Oncosur60
招募中
2 期
Remdesivir in treatment of COVID-19IRCT20171122037571N2Tehran University of Medical Sciences120
尚未招募
不适用
A single arm, Multicenter study evaluating efficacy of beta 2-microglobulin adsorption column on dialysis-related amyloidosisEnd-stage renal disease, Dialysis-related amyloidosisJPRN-UMIN000031418Hirosaki University School of Medicine30
招募中
3 期
A study to investigate the pharmacokinetics and safety of dupilumab in participants >=2 years to < 12 years of age with uncontrolled chronic spontaneous urticaria (CSU) or chronic inducible cold urticaria (CICU)JPRN-jRCT2031220733Tanaka Tomoyuki24
招募中
1 期
To evaluate the safety tolerability and performance of the liver assist device (EBDLR System) in patients suffering from Acute Liver FailureCTRI/2024/02/062612Ykrita Life sciences Pvt Ltd.